NO160258C - Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridazinonimin-derivater. - Google Patents

Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridazinonimin-derivater.

Info

Publication number
NO160258C
NO160258C NO823682A NO823682A NO160258C NO 160258 C NO160258 C NO 160258C NO 823682 A NO823682 A NO 823682A NO 823682 A NO823682 A NO 823682A NO 160258 C NO160258 C NO 160258C
Authority
NO
Norway
Prior art keywords
preparation
pyridazinonimine
derivatives
pharmacologically active
analogy procedure
Prior art date
Application number
NO823682A
Other languages
English (en)
Other versions
NO160258B (no
NO823682L (no
Inventor
Rudolf Kropp
Marco Thyes
Rainer Schlecker
Albrecht Franke
Franz Reicheneder
August Amann
Hans-Juergen Teschendorf
Rolf Kretzschmar
Martin Traut
Josef Gries
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO823682L publication Critical patent/NO823682L/no
Publication of NO160258B publication Critical patent/NO160258B/no
Publication of NO160258C publication Critical patent/NO160258C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22Nitrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO823682A 1981-11-06 1982-11-05 Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridazinonimin-derivater. NO160258C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813144138 DE3144138A1 (de) 1981-11-06 1981-11-06 Neue pyridazinonimine und ihre physiologisch vertraeglichen saeureadditionssalze, verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel

Publications (3)

Publication Number Publication Date
NO823682L NO823682L (no) 1983-05-09
NO160258B NO160258B (no) 1988-12-19
NO160258C true NO160258C (no) 1989-03-29

Family

ID=6145799

Family Applications (1)

Application Number Title Priority Date Filing Date
NO823682A NO160258C (no) 1981-11-06 1982-11-05 Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridazinonimin-derivater.

Country Status (10)

Country Link
US (1) US4820821A (no)
EP (1) EP0078989B1 (no)
JP (1) JPS5885870A (no)
AT (1) ATE13181T1 (no)
CA (1) CA1183534A (no)
DE (2) DE3144138A1 (no)
DK (1) DK492282A (no)
FI (1) FI74955C (no)
NO (1) NO160258C (no)
ZA (1) ZA828127B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3542197A1 (de) * 1985-11-29 1987-06-04 Basf Ag Neue 1-phenyl-4-(1h)-pyridazinimine, ihre herstellung und verwendung
US9247745B2 (en) 2010-07-22 2016-02-02 Basf Se Substituted pyridazines for controlling invertebrate pests

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1050535A (no) * 1963-03-19
DE1542693A1 (de) * 1965-08-19 1970-07-23 Basf Ag Herbizid
DE1770772A1 (de) * 1968-07-02 1971-11-25 Basf Ag Verfahren zur Herstellung von Pyridazoniminen
DE1912941C3 (de) * 1969-03-14 1980-06-26 Basf Ag, 6700 Ludwigshafen 1 -Phenyl^-amino-e-methoxypyridaziniumsalze
BE787275A (fr) * 1971-08-07 1973-02-07 Basf Ag Remedes cardio-et vaso-actifs, en particulier hypertensifs
DE2211662A1 (de) * 1972-03-10 1973-09-20 Basf Ag Verfahren zur umwandlung von pyridaziniumsalzen
DE2245248C2 (de) * 1972-09-15 1983-06-09 Basf Ag, 6700 Ludwigshafen 1-Phenyl-4-aminopyridaziniumsalze
US4011220A (en) * 1972-09-15 1977-03-08 Basf Aktiengesellschaft Pyridazinium compounds and a process for their production
US4648896A (en) * 1982-11-15 1987-03-10 Ciba-Geigy Corporation 2-aryl-4,6-dihalopyrimidines as antidote for protecting cultivated plants from phytotoxic damage caused by herbicides

Also Published As

Publication number Publication date
CA1183534A (en) 1985-03-05
FI823762L (fi) 1983-05-07
EP0078989B1 (de) 1985-05-08
FI823762A0 (fi) 1982-11-03
US4820821A (en) 1989-04-11
DE3144138A1 (de) 1983-05-19
EP0078989A1 (de) 1983-05-18
JPS5885870A (ja) 1983-05-23
FI74955B (fi) 1987-12-31
DE3263688D1 (en) 1985-06-13
ATE13181T1 (de) 1985-05-15
FI74955C (fi) 1988-04-11
ZA828127B (en) 1983-10-26
NO160258B (no) 1988-12-19
DK492282A (da) 1983-05-07
NO823682L (no) 1983-05-09

Similar Documents

Publication Publication Date Title
DE59009074D1 (de) Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus.
ES8202799A1 (es) Procedimiento para la preparacion de sulfonilureas
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
ES520226A0 (es) Procedimiento para la preparacion de derivados de cefem.
SE8700499D0 (sv) Novel pharmacologically active compounds
NO894616D0 (no) Fremgangsmaate for fremstilling av anti-aterosklerotisk aktive diarylforbindelser.
DE3361757D1 (en) Salicylic-acid derivatives, process for their preparation, pharmaceutical preparations based on these compounds and their use
NO172537C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater
ES547620A0 (es) Procedimiento para preparar pirazol (3,4-b) piridinamidas.
ES525441A0 (es) Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
NO160258C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridazinonimin-derivater.
DK114286A (da) Pyridylmethylnaphthylderivater eller fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler
ATE37548T1 (de) Thiazaspiranderivate, verfahren zu ihrer herstellung und arzneimittel.
DK114186D0 (da) Imidazolylforbindelser eller fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler
IE37288B1 (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
ES8107189A1 (es) Procedimiento para la preparacion de sulfonilureas
IE43848L (en) Pharmaceutical compositions
JO1664B1 (en) The compound has the effect of immobilizing gastric acid and the process of preparing it